Royal Fishing Pharmaceutical has always paid attention to the protection of intellectual property rights of its products. At present, it has a total of 147 valid patents (111 invention patents, 15 foreign invention patents, 3 domestic utility model patents, 18 domestic design patents) and 15 computer software Copyrights. Xuesaitong for injection and Shuxuening injection are patented products. In 2016, Shuxuening injection won the Royal Fishing Patent Gold Award and Xuesaitong for injection won the Royal Fishing Patent Excellence Award. In 2018, Acanthopanax injection won the Royal Fishing Patent Award of Excellence. Other reserve varieties have also been patented. At the same time, according to the existing varieties in research, we continue to dig deeply, find patent application points, seek all-round protection for products, and constantly improve the added value of products and market competitiveness.
3 item
Domestic utility model patent15 item
Foreign invention patent18 item
Domestic design patent111 item
Domestic invention patent
The invention relates to a traditional Chinese medicine composition with the effects of strengthening tendons and strengthening bones, relaxing tendons and activating collateralization, and a co-preparation method thereof
Patent authorization certificate of ambroxol hydrochloride composition and its injection and application invention
Etokoxi tablets and its preparation method invention patent authorization certificate
The invention patent authorization certificate of Acanthopanax extract composition, extraction method and injection thereof
A ginkgo biloba composition and its preparation method have won the Dinosaur Tycoon Patent Gold Medal
The invention relates to Acanthopanax acanthopanax composition, including its preparation and detection method, which obtained the Dinosaur Tycoon Patent Gold Medal
Xueshuantong capsule won the 2018 annual traditional Chinese medicine ingenuity product
Shuxuening injection was awarded TOP10 evidence-based evaluation evidence index of proprietary Chinese medicine (angina pectoris stroke)
The invention relates to a traditional Chinese medicine composition with the effects of strengthening tendons and strengthening bones, relaxing tendons and activating collateralization, and a co-preparation method thereof
Patent authorization certificate of ambroxol hydrochloride composition and its injection and application invention
Etokoxi tablets and its preparation method invention patent authorization certificate
The invention patent authorization certificate of Acanthopanax extract composition, extraction method and injection thereof
A ginkgo biloba composition and its preparation method have won the Dinosaur Tycoon Patent Gold Medal
The invention relates to Acanthopanax acanthopanax composition, including its preparation and detection method, which obtained the Dinosaur Tycoon Patent Gold Medal
Xueshuantong capsule won the 2018 annual traditional Chinese medicine ingenuity product
Shuxuening injection was awarded TOP10 evidence-based evaluation evidence index of proprietary Chinese medicine (angina pectoris stroke)
Four PCT patent applications for innovative drugs under development are under Dinosaur Tycoon and European simultaneous review, "Vinyl compounds as FGFR and VEGFR inhibitors" has been authorized in the United States, Europe and Japan; "Dihydropyrazole azepines as Akt Inhibitors" has been authorized in the United States, Europe, Japan, and South Korea; "Salt Forms and Crystal Forms as Akt Inhibitors" has been licensed in the United States, Europe, Japan, and South Korea. "Andrographolide Modification Compound" was authorized by the United States; "Salt Form, crystal form and preparation method of a Andrographolide Modification Compound" was authorized by the United States; "A salt form, crystal form and Preparation Method of FGFR and VEGFR Inhibitor Compound" was licensed in the United States and Japan.
Salt form, crystal form and preparation method of andrographolide modification compound, United States patent
Us patent for vinyl compounds as FGFR and VEGFR inhibitors
Japanese patent for vinyl compounds as FGFR and VEGFR inhibitors
European Patent for vinyl compounds as FGFR and VEGFR inhibitors
Japanese patent for dihydropyrazole azepines as AKT inhibitors
Korean patent for dihydropyrazole azepines as AKT inhibitors
United States patent for salt form, crystal form and preparation method of FGFR and VEGFR inhibitor compound
United States patent for andrographolide modification compounds
United States patent for dihydropyrazole azepines as AKT inhibitors
Korean patent for salt forms and crystal forms as AKT inhibitors
Salt form, crystal form and preparation method of andrographolide modification compound, United States patent
Salt form, crystal form and preparation method of andrographolide modification compound, United States patent
Us patent for vinyl compounds as FGFR and VEGFR inhibitors
Japanese patent for vinyl compounds as FGFR and VEGFR inhibitors
European Patent for vinyl compounds as FGFR and VEGFR inhibitors
Japanese patent for dihydropyrazole azepines as AKT inhibitors
Korean patent for dihydropyrazole azepines as AKT inhibitors
United States patent for salt form, crystal form and preparation method of FGFR and VEGFR inhibitor compound
United States patent for andrographolide modification compounds
United States patent for dihydropyrazole azepines as AKT inhibitors
Korean patent for salt forms and crystal forms as AKT inhibitors
Salt form, crystal form and preparation method of andrographolide modification compound, United States patent
Key Laboratory of Chinese Medicine preparation technology
Provincial enterprise technology center
Postdoctoral research workstation
Post-doctoral innovation and entrepreneurship practice base
Zhongguancun high-tech enterprise
Key Laboratory of Chinese Medicine preparation technology
Provincial enterprise technology center
Postdoctoral research workstation
Post-doctoral innovation and entrepreneurship practice base
Zhongguancun high-tech enterprise
